However, establishing clonal cell linesfrom these tumors enabled the generation of an immunogenic syngeneictransplantation model of KRAS-mutant lung adenocarcinoma that was sensitive toimmunotherapy. This evidence concerns the gene KRAS and lung adenocarcinoma.